CD38 and systemic lupus erythematosus: We found that higher levels of CD38+ (Figure 2B) and CD38+HLA-DR+ double-positive activated T cells, monocytes, pDCs, and NK cells correlated with increased disease activity in all patients with SLE (Supplemental Figure 5, A–H).